HIV protease inhibitors and intermediates

Details HIV protease inhibitors and intermediates HIV protease inhibitors and intermediates

1996-08-05

1998-03-31

Ivy, C. Warren

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C07D47106, C07D51304

Patent

active

057340579

ABSTRACT:
The present invention provides HIV protease inhibitors, intermediates for preparing HIV protease inhibitors. The enzyme, HIV protease, represents a viable target for the inhibition of HIV viral replication, thus providing a method for treating and/or preventing HIV infection.

REFERENCES:
patent: 4161599 (1979-07-01), Maffrand
patent: 4174448 (1979-11-01), Bousquet et al.
patent: 4749692 (1988-06-01), Blanchard et al.
patent: 5026700 (1991-06-01), Harrison et al.
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5196438 (1993-03-01), Martin et al.
patent: 5232928 (1993-08-01), Skiles
patent: 5480887 (1996-01-01), Hornback
Roberts et al., Science, 248, 358-361 (1990).
Thaisrivongs et al., J. Med. Chem., 34, 2344-2356 (1991).
Ghosh et al., J. Med. Chem., 37, 1177-1188 (1994).
Ghosh et al., J. Med. Chem., 37, 2506-2508 (1994).
Kim et al., Tetrahedron Letters, 34(41), 6517-6520 (1993).
Kong-Teck Chong et al., J. Med. Chem., 36, 2575-2577 (1993).
Ghosh et al., J. Med. Chem., 36, 924-927 (1993), ibid 292-294.

Affiliated with

Also associated with

Rating

HIV protease inhibitors and intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV protease inhibitors and intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV protease inhibitors and intermediates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-53486